Calleja, José Luis <br/><br/>
Ferric carboxymaltose reduces transfusions and hospital stay in patients with colon cancer and anemia.  [electronic resource] 

 -  International journal of colorectal disease  Mar 2016 
 - 543-51 p.  digital 
<br/><br/> Publication Type: Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1432-1262 
<br/><br/><label>Standard No.: </label>10.1007/s00384-015-2461-x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Anemia--blood<br/>Blood Transfusion<br/>Colonic Neoplasms--blood<br/>Erythrocyte Indices<br/>Female<br/>Ferric Compounds--therapeutic use<br/>Hemoglobins--metabolism<br/>Humans<br/>Iron--metabolism<br/>Length of Stay<br/>Male<br/>Maltose--analogs & derivatives<br/>Postoperative Complications--etiology<br/>Transplantation, Homologous<br/>Treatment Outcome